Clinical Trial Update: A Study of a Live Intranasal Influenza Vaccine in Children With Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and immunogenicity of a live intranasal influenza vaccine in pediatric cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• FluMist (live attenuated influenza vaccine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Cancer | Phase 1 | Status: COMPLETED